IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 318 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,000 | -18.2% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $11,000 | -71.1% | 200 | -69.0% | 0.00% | – |
| Q1 2020 | $38,000 | 0.0% | 646 | 0.0% | 0.00% | – |
| Q4 2019 | $38,000 | +245.5% | 646 | +213.6% | 0.00% | – |
| Q3 2019 | $11,000 | -8.3% | 206 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | -25.0% | 206 | 0.0% | 0.00% | – |
| Q1 2019 | $16,000 | +45.5% | 206 | -6.8% | 0.00% | – |
| Q4 2018 | $11,000 | +10.0% | 221 | +10.5% | 0.00% | – |
| Q3 2018 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2018 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2017 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | -65.5% | 200 | -72.4% | 0.00% | – |
| Q2 2017 | $29,000 | 0.0% | 724 | 0.0% | 0.00% | – |
| Q1 2017 | $29,000 | -12.1% | 724 | +2.0% | 0.00% | – |
| Q4 2016 | $33,000 | +32.0% | 710 | 0.0% | 0.00% | – |
| Q3 2016 | $25,000 | -34.2% | 710 | -58.5% | 0.00% | – |
| Q2 2016 | $38,000 | +850.0% | 1,710 | +1454.5% | 0.00% | – |
| Q1 2016 | $4,000 | -33.3% | 110 | 0.0% | 0.00% | – |
| Q4 2015 | $6,000 | – | 110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
| Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
| Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
| SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
| Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
| Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
| Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
| ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |